X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48174) 48174
Book Review (4856) 4856
Publication (4013) 4013
Newsletter (2922) 2922
Newspaper Article (590) 590
Book Chapter (208) 208
Conference Proceeding (191) 191
Dissertation (46) 46
Magazine Article (23) 23
Trade Publication Article (17) 17
Book / eBook (15) 15
Data Set (7) 7
Reference (6) 6
Web Resource (5) 5
Transcript (2) 2
Poster (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39474) 39474
humans (31397) 31397
male (21040) 21040
female (18213) 18213
apolipoproteins (16434) 16434
animals (13599) 13599
middle aged (12103) 12103
aged (10424) 10424
atherosclerosis (9284) 9284
adult (8961) 8961
cholesterol (8459) 8459
mice (8239) 8239
risk factors (7732) 7732
apolipoproteins e - genetics (7520) 7520
biochemistry & molecular biology (6864) 6864
lipids (6730) 6730
alzheimer's disease (6500) 6500
analysis (6474) 6474
research (6080) 6080
apolipoprotein-e (5628) 5628
apolipoprotein e (5199) 5199
neurosciences (5096) 5096
lipoproteins (4955) 4955
genotype (4882) 4882
proteins (4459) 4459
aged, 80 and over (4254) 4254
triglycerides - blood (4233) 4233
genetic aspects (4112) 4112
peripheral vascular disease (4023) 4023
cholesterol - blood (4012) 4012
risk (3891) 3891
physiological aspects (3841) 3841
alzheimers-disease (3637) 3637
abridged index medicus (3603) 3603
metabolism (3416) 3416
alzheimer disease - genetics (3340) 3340
dementia (3269) 3269
mice, knockout (3214) 3214
cholesterol, hdl - blood (3181) 3181
mice, inbred c57bl (3141) 3141
lipids - blood (3087) 3087
inflammation (3045) 3045
alleles (2970) 2970
cardiac & cardiovascular systems (2969) 2969
low density lipoproteins (2901) 2901
disease (2896) 2896
clinical neurology (2880) 2880
expression (2862) 2862
apolipoprotein-a-i (2861) 2861
article (2819) 2819
cardiovascular disease (2776) 2776
endocrinology & metabolism (2741) 2741
apolipoproteins b - blood (2690) 2690
plasma (2684) 2684
cholesterol, ldl - blood (2671) 2671
medical research (2619) 2619
cell biology (2613) 2613
gene expression (2597) 2597
association (2590) 2590
health aspects (2577) 2577
low-density-lipoprotein (2528) 2528
triglycerides (2485) 2485
lipoproteins - blood (2395) 2395
genes (2358) 2358
high-density-lipoprotein (2303) 2303
case-control studies (2295) 2295
rats (2272) 2272
cardiovascular-disease (2270) 2270
apolipoproteins - blood (2257) 2257
brain (2257) 2257
medicine (2233) 2233
research article (2206) 2206
polymorphism, genetic (2204) 2204
rodents (2151) 2151
genetics (2145) 2145
disease models, animal (2140) 2140
coronary-heart-disease (2118) 2118
multidisciplinary sciences (2097) 2097
myocardial-infarction (2082) 2082
genetics & heredity (2049) 2049
studies (2031) 2031
lipoprotein (2029) 2029
phenotype (2012) 2012
adolescent (1995) 1995
genetic predisposition to disease (1994) 1994
medicine, research & experimental (1993) 1993
mutation (1990) 1990
polymorphism (1990) 1990
medicine, experimental (1984) 1984
apolipoprotein-b (1977) 1977
neurology (1934) 1934
diabetes (1913) 1913
molecular sequence data (1903) 1903
apolipoproteins e - deficiency (1893) 1893
nutrition & dietetics (1890) 1890
oxidative stress (1888) 1888
lipid metabolism (1883) 1883
hypercholesterolemia (1857) 1857
cardiovascular (1830) 1830
liver - metabolism (1829) 1829
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51122) 51122
Chinese (148) 148
Russian (127) 127
French (121) 121
Japanese (104) 104
Spanish (96) 96
German (56) 56
Polish (25) 25
Korean (19) 19
Italian (18) 18
Czech (14) 14
Portuguese (12) 12
Hungarian (3) 3
Slovak (3) 3
Turkish (3) 3
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proteomics, ISSN 1615-9853, 02/2005, Volume 5, Issue 2, pp. 551 - 565
The molecular mechanisms underlying the relationship between low-density lipoprotein (LDL) and the risk of atherosclerosis are not clear. Therefore, detailed... 
Low-density lipoprotein | Matrix assisted laser desorption/ ionization-time of flight-mass spectrometry | Tandem mass spectrometry | Lysozyme | Two-dimensional gel electrophoresis | SITE | lysozyme | ACID | HUMAN PLASMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | matrix assisted laser desorption | BIOCHEMICAL RESEARCH METHODS | GLYCOSYLATION | ionization-time of flight-mass spectrometry | low-density lipoprotein | tandem mass spectrometry | LDL | INFLAMMATION | HUMAN NASAL | BINDING | ASSOCIATION | two-dimensional gel electrophoresis | APOLIPOPROTEIN-A-I | Humans | Apolipoprotein A-I - analysis | Apolipoprotein B-100 | Electrophoresis, Gel, Two-Dimensional | Apolipoproteins C - analysis | Apolipoproteins E - analysis | Clusterin | Sequence Analysis, Protein | Apolipoproteins M | Lipocalins | Spectrometry, Mass, Electrospray Ionization | Apolipoprotein C-III | Peptide Mapping | Mass Spectrometry | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Molecular Chaperones - analysis | Centrifugation, Density Gradient | Calgranulin A - analysis | Lipoproteins, LDL - isolation & purification | Lipoproteins, LDL - analysis | Apolipoproteins A - analysis | Protein Isoforms - analysis | Proteome - analysis | Proteomics | Apolipoproteins - analysis | Glycoproteins - analysis | Chromatography, Gel | Apolipoproteins B - analysis | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Matrix assisted laser desorption/ionization-time of flight-mass spectrometry | MEDICINE
Journal Article
Cellular and Molecular Neurobiology, ISSN 0272-4340, 8/2008, Volume 28, Issue 5, pp. 737 - 744
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2009, Volume 53, Issue 23, pp. 2186 - 2196
Objectives: This study sought to define the relationship between oxidative biomarkers, cardiovascular disease (CVD) risk factors, and inflammatory and... 
oxidation | risk factors | statins | acute coronary syndromes | lipoproteins | ATHEROSCLEROTIC LESIONS | ANTIBODIES | OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | CAROTID ATHEROSCLEROSIS | APOLIPOPROTEIN B-100 PARTICLES | PLAQUE STABILIZATION | PLASMA-LEVELS | LDL | SHORT-TERM | ARTERY-DISEASE | Apolipoproteins B - metabolism | Reactive Oxygen Species | Heptanoic Acids - therapeutic use | Humans | Immunoglobulin M - analysis | Middle Aged | Phospholipids - analysis | Acute Coronary Syndrome - physiopathology | Male | Cholesterol, LDL - analysis | Aged, 80 and over | Autoantibodies - analysis | Female | Lipoprotein(a) - analysis | Immunoglobulin G - analysis | Apolipoproteins B - chemistry | Phospholipids - metabolism | Pyrroles - therapeutic use | Thromboembolism | Cholesterol, LDL - immunology | Oxidation-Reduction | Risk Factors | Biomarkers - analysis | Acute Coronary Syndrome - immunology | Acute Coronary Syndrome - drug therapy | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Cholesterol, LDL - metabolism | Aged | Apolipoproteins B - immunology | Cohort Studies | Inflammation - physiopathology | Heart attacks | Acute coronary syndromes | Drug therapy | Cholesterol | Cell adhesion & migration | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2013, Volume 72, Issue 4, pp. 560 - 565
Objective An atherogenic lipid profile is an established risk factor for cardiovascular (CV) diseases. Interestingly, high inflammatory states as present in... 
DIABETES-MELLITUS | LIPID PROFILE | CHOLESTEROL | ACCELERATED ATHEROSCLEROSIS | IMPROVEMENT | RHEUMATOLOGY | NECROSIS FACTOR THERAPY | CORONARY-HEART-DISEASE | MURINE MODELS | HIGH-DENSITY-LIPOPROTEIN | CARDIOVASCULAR RISK-FACTORS | Immunomodulation - drug effects | Arthritis, Rheumatoid - blood | Humans | Middle Aged | Male | Apolipoproteins B - blood | Cholesterol, LDL - analysis | Atherosclerosis - epidemiology | Apolipoproteins A - blood | Triglycerides - analysis | Arthritis, Rheumatoid - drug therapy | Adult | Cholesterol, LDL - blood | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Antirheumatic Agents - therapeutic use | Risk Factors | Arthritis, Rheumatoid - epidemiology | Apolipoproteins A - analysis | Rituximab | Treatment Outcome | Atherosclerosis - blood | Proteomics | Triglycerides - blood | Cholesterol, HDL - blood | Aged | Cholesterol, HDL - analysis | Apolipoproteins B - analysis | Atherosclerosis - prevention & control | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunomodulation - immunology | Complications and side effects | Care and treatment | Cardiovascular diseases | Rheumatoid arthritis | Risk factors | Drugs | Mortality | Rheumatology | Lipids | Metabolism | Cholesterol | Proteins | Lipoproteins | Atherosclerosis | Rheumatism | Tumor necrosis factor-TNF | Statins | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Analyst, ISSN 0003-2654, 2/2015, Volume 14, Issue 4, pp. 126 - 136
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2006, Volume 44, Issue 4, pp. 732 - 741
The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fully understood. In mice, NASH can be inhibited by fenofibrate, a synthetic... 
Hyperlipidemia | Inflammation | APOE | Microarray | Non-alcoholic steatohepatitis | PPARa | Triglyceride | Cholesterol | Steatosis | Western diet | triglyceride | PPAR-ALPHA | hyperlipidemia | ATHEROGENIC DIET | RECEPTOR | INDUCTION | western diet | microarray | III HYPERLIPOPROTEINEMIA | METABOLISM | inflammation | FREE FATTY-ACIDS | GENE-EXPRESSION | cholesterol | GASTROENTEROLOGY & HEPATOLOGY | steatosis | NF-KAPPA-B | non-alcoholic steatohepatitis | Immunohistochemistry | Intercellular Signaling Peptides and Proteins - analysis | Liver - pathology | Oligonucleotide Array Sequence Analysis | Fatty Liver - chemically induced | Phospholipases A - analysis | ATP-Binding Cassette Transporters - genetics | Disease Models, Animal | Macrophages - physiology | Macrophages - pathology | Liver - metabolism | Fatty Liver - prevention & control | Hypolipidemic Agents - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Hyperlipidemias - prevention & control | Stearoyl-CoA Desaturase - genetics | Disease Progression | Liver - chemistry | ATP-Binding Cassette Transporters - analysis | Apolipoprotein E2 | Mice, Knockout | Phospholipases A - genetics | Hypolipidemic Agents - therapeutic use | Inflammation - prevention & control | Mice | Hyperlipidemias - chemically induced | Inflammation - chemically induced | Hyperlipidemias - genetics | Gene Expression - drug effects | Liver - physiopathology | Fenofibrate - therapeutic use | Clofibric Acid - pharmacology | Fenofibrate - pharmacology | Clofibric Acid - therapeutic use | Female | Vascular Cell Adhesion Molecule-1 - genetics | Hyperlipidemias - physiopathology | Fatty Liver - genetics | Peroxisome Proliferator-Activated Receptors - agonists | Dietary Fats - adverse effects | Fatty Liver - physiopathology | Intercellular Signaling Peptides and Proteins - genetics | Stearoyl-CoA Desaturase - analysis | Animals | Apolipoproteins E - genetics | Apolipoproteins E - physiology | Inflammation - genetics | Vascular Cell Adhesion Molecule-1 - analysis | Inflammation - physiopathology | Molecular genetics | Analysis | Triglycerides | Index Medicus
Journal Article
Kidney International, ISSN 0085-2538, 04/2017, Volume 91, Issue 4, pp. 964 - 971
Journal Article